Mori S - Search Results

1

Efficacy of the combined use of bevacizumab and irinotecan as a postoperative adjuvant chemotherapy in colon carcinoma.

Mizobe T, Ogata Y, Murakami H, Akagi Y, Ishibashi N, Mori S, Sasatomi T, Shirouzu K. Mizobe T, et al. Among authors: mori s. Oncol Rep. 2008 Sep;20(3):517-23. Oncol Rep. 2008. PMID: 18695900

2

Dosage escalation study of S-1 and irinotecan in metronomic chemotherapy against advanced colorectal cancer.

Ogata Y, Sasatomi T, Akagi Y, Ishibashi N, Mori S, Shirouzu K. Ogata Y, et al. Among authors: mori s. Kurume Med J. 2009;56(1-2):1-7. doi: 10.2739/kurumemedj.56.1. Kurume Med J. 2009. PMID: 20103995 Free article. Clinical Trial.

3

Metronomic chemotherapy using weekly low-dosage CPT-11 and UFT as postoperative adjuvant therapy in colorectal cancer at high risk to recurrence.

Ogata Y, Mori S, Ishibashi N, Akagi Y, Ushijima M, Murakami H, Fukushima T, Shirouzu K. Ogata Y, et al. Among authors: mori s. J Exp Clin Cancer Res. 2007 Dec;26(4):475-82. J Exp Clin Cancer Res. 2007. PMID: 18365541

4

Long-Term Outcomes of Pancreatic Function Following Pancreatic Trauma.

Morita T, Takasu O, Sakamoto T, Mori S, Nakamura A, Nabeta M, Hirayu N, Moroki M, Yamashita N. Morita T, et al. Among authors: mori s. Kurume Med J. 2017 May 8;63(3.4):53-60. doi: 10.2739/kurumemedj.MS00001. Epub 2017 Apr 3. Kurume Med J. 2017. PMID: 28381727 Free article.

5

C-peptide index at 2 h post-meal is a useful predictor of endogenous insulin secretory capacity and withdrawal from insulin therapy in subjects with type 2 diabetes.

Iwamoto Y, Kimura T, Shimoda M, Morimoto Y, Watanabe Y, Itoh T, Sasaki T, Mori S, Kubo M, Takenouchi H, Dan K, Iwamoto H, Sanada J, Fushimi Y, Katakura Y, Nakanishi S, Mune T, Kaku K, Kaneto H. Iwamoto Y, et al. Among authors: mori s. Diabetes Obes Metab. 2024 Apr 22. doi: 10.1111/dom.15595. Online ahead of print. Diabetes Obes Metab. 2024. PMID: 38646845

6

Cardiac blood vessels and irreversible electroporation: findings from pulsed field ablation.

Chinyere IR, Mori S, Hutchinson MD. Chinyere IR, et al. Among authors: mori s. Vessel Plus. 2024;8:7. doi: 10.20517/2574-1209.2023.80. Epub 2024 Jan 30. Vessel Plus. 2024. PMID: 38646143 Free PMC article.

7

[A Case of Conversion Surgery for Unresectable Advanced Gastric Cancer of Which Metastatic Site Was Disappear by Chemotherapy but the Primary Site Was Enlarged after Five Years].

Nomura A, Akamaru Y, Nishida K, Mori S, Yasuyama A, Nomura M, Yoshikawa Y, Tamai K, Takiuchi D, Hamakawa T, Tei M, Tsujie M. Nomura A, et al. Among authors: mori s. Gan To Kagaku Ryoho. 2024 Apr;51(4):473-475. Gan To Kagaku Ryoho. 2024. PMID: 38644326 Japanese.

8

Discovery and Structure-Activity Relationship of a Ryanodine Receptor 2 Inhibitor.

Ishida R, Zeng X, Kurebayashi N, Murayama T, Mori S, Kagechika H. Ishida R, et al. Among authors: mori s. Chem Pharm Bull (Tokyo). 2024;72(4):399-407. doi: 10.1248/cpb.c24-00114. Chem Pharm Bull (Tokyo). 2024. PMID: 38644198

9

Retrospective analysis on diameters of drug-coated balloons and predilatation balloons in infra-inguinal endovascular treatment (RABBIT study).

Iwata Y, Takahara M, Tobita K, Hayakawa N, Mori S, Horie K, Nakama T, Suzuki K, Fukuzawa S. Iwata Y, et al. Among authors: mori s. Cardiovasc Interv Ther. 2024 Apr 17. doi: 10.1007/s12928-024-01001-9. Online ahead of print. Cardiovasc Interv Ther. 2024. PMID: 38632168

10

Mechanochemical synthesis of fluoride-ion conducting glass and glass-ceramic in ZrF₄-BaF₂ binary system.

Motohashi K, Higuchi H, Nakajima H, Mori S, Sakuda A, Hayashi A. Motohashi K, et al. Among authors: mori s. Sci Rep. 2024 Apr 16;14(1):8808. doi: 10.1038/s41598-024-59040-4. Sci Rep. 2024. PMID: 38627428 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

5,228 results

Search Page